CHRISTOPHER O'BARR: Open Payments
NPI 1023493509 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$887 in 40 payments from 12 companies in 2025. Trend: 2023 $746 · 2024 $967 · 2025 $887
Food & beverage: $887
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $210 |
| GlaxoSmithKline, LLC. | 8 | $173 |
| Janssen Pharmaceuticals, Inc | 2 | $116 |
| Novo Nordisk Inc | 4 | $88 |
| Corcept Therapeutics | 3 | $73 |
| Abbott Laboratories | 3 | $62 |
| Exact Sciences Corporation | 2 | $45 |
| Philips North America LLC | 2 | $33 |
| Lilly USA, LLC | 2 | $33 |
| Intra-Sana Laboratories | 1 | $23 |
Products named: SPRAVATO, TRELEGY ELLIPTA, Korlym, SHINGRIX, FREESTYLE LIBRE 3, AIRSUPRA, BREZTRI, FARXIGA.
Industry payments across AL — which companies pay providers there.
